NanoVibronix and Mio-Guard have signed a distribution agreement for the former’s PainShield MD product.
As part of the multi-year agreement, Mio-Guard will exclusively sell and distribute PainShield MD products to its US customers in the areas of athletic team sports and sports medicine.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Mio-Guard already ordered its first lot of PainShield MD products and plans to showcase them at the National Athletic Trainers’ Association (NATA) Expo.
Mio-Guard CEO Ken Zisholz said: “This agreement is very exciting for Mio-Guard, the opportunity to represent this world-class product to our customers in the US is a tremendous one. We are very excited to feature the PainShield MD at the NATA Expo in Indianapolis next week.”
PainShield, a type of ultrasound therapy for pain, offers quick pain relief for nerve and soft tissue damage.
Designed to be used immediately post-injury and post-op, PainShield can be used to treat both chronic and acute pain.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNanoVibronix CEO Brian Murphy said: “This new distribution agreement is a great opportunity for us to expand our footprint in sports medicine and within the realm of organised sports teams at various levels.
“Sports medicine represents a $5bn opportunity in the US and has gained traction in recent years due to the rising incidence of sports injuries and growing participation in sports and fitness-related activities.”
NanoVibronix also provides UroShield, a urology therapy device with a disposable clip and a driver.
The clip-on UroShield device can be attached to all external urinary tract catheters to offer relief from spasms and catheter pain.
